Drug pricing white paper allays pharma patent fears, but innovators should remain vigilant
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Life sciences reporter
@IAM_Alerts RT @WIPO: Released today:
Global Innovation Index 2021🌐💡📊
The world’s innovation leaders:
4. U.K.🇬🇧… Read more
@IAM_Alerts RT @AMorrisReports: The IEEE’s 2015 patent policy has proved to be enduringly controversial and now stakeholders have the chance to comment… Read more
@IAM_Alerts This week's Sunday Supplement: Top Qualcomm exec slams Apple; NTT and Oppo agree SEP deal; Uber and Cruise form aut… https://t.co/d0HtUfpUau Read more
@IAM_Alerts IP and licensing failures are holding back adoption of new video codecs, says Micky Minhas in this week’s Saturday… https://t.co/9mEmAimuL4 Read more